Navigation Links
BioProcessors Launches SimCell(TM) Services to Meet Increased Customer Demand
Date:9/26/2007

WOBURN, Mass., Sept. 26 /PRNewswire/ -- BioProcessors Corporation, a leading innovator of high-throughput cell culture-based solutions for biopharmaceutical process development, expands its Woburn operations and launches new SimCell Services offering.

"We continue to see strong interest in our SimCell technology," said Jonathan Rennert, President and CEO, BioProcessors Corporation. "The biopharmaceutical industry is accelerating its pace to clinical trials in order to identify successful therapeutic candidates sooner. Expanding our capacity and scope allows the company to respond more quickly and effectively to this key market need."

A second SimCell System was recently installed as part of an expanded laboratory and training wing at BioProcessors' Woburn facility. "Two high- throughput Robotic Systems, along with supporting analytical instrumentation and a new multi-media customer training center, provide our new team of cell culture specialists with much more comprehensive applications development and training capabilities," added Rennert. "We are now positioned to expand customer access to SimCell technology through the introduction of our new SimCell Services."

SimCell Services are customized service offerings tailored to meet specific cell culture application requirements of BioProcessors' clients. They provide access to SimCell technology through a hosted cell culture development project, which can range in scope from a simple screening experiment to more comprehensive production clone selection, clone stability, media optimization, or process development experiments. SimCell Services help clients gain better insight into their bioprocesses and reduce development risk by enabling the design of robust, optimized bioprocesses, faster and more efficiently.

About BioProcessors Corporation

BioProcessors Corporation is a developer and provider of micro-engineered solutions for cell culture-based upstream bioprocess development. The Company's SimCell technology provides the capability to perform high throughput cell culture experiments for the development and optimization of biopharmaceutical manufacturing processes. The high throughput capability of the system enables execution of full and fractional factorial statistical experiments at a fraction of the time and cost associated with conventional scale-down technologies. The result is greater insight and reduced risk for bioprocess development decision making.

For more information on BioProcessors Corporation, contact Eric Denoyer, Marketing Director, BioProcessors Corporation +1 781-305-8867, e.denoyer@bioprocessors.com, or visit http://www.bioprocessors.com.


'/>"/>
SOURCE BioProcessors Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
8. Pfizer Launches Viagra For Lung Disease In UK
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 07, 2016 , ... “The Road To Restoration”: an informative and enlightening ... hour a week showing of hands. “The Road To Restoration” is the creation of ... familiar with the brass ring that you could reach out for, and grab, on ...
(Date:12/7/2016)... ... 07, 2016 , ... “Fred Rides a Train” allows readers to tag along ... “Fred Rides a Train” is the creation of published author, Janet Morrison, who has ... in Michigan. The "Fred, the Dog" series is her first attempt at writing for ...
(Date:12/7/2016)... WI (PRWEB) , ... December 07, 2016 , ... ... Labs, was honored to present at the International Probiotic Association’s Washington DC workshop ... and government regulators to engage in dialog regarding probiotic dietary supplement regulations. ...
(Date:12/6/2016)... ... December 06, 2016 , ... People ... can be seen on a type of MRI, according to a study appearing ... of the central nervous system characterized by tremors or trembling and stiffness in ...
(Date:12/6/2016)... ... December 06, 2016 , ... Individuals who seek to reduce ... drinking more water or limiting their exposure to the sun, according to a November ... group Beverly Hills Physicians (BHP) notes that, while preventive measures to help keep ourselves ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... , Dec. 7, 2016  Varian Medical Systems (NYSE: ... its previously announced plans to separate its Imaging Components ... a tax-free distribution to Varian stockholders of common stock ... that will hold the Imaging Components business.  As part ... executed by the end of January 2017, Varian will ...
(Date:12/7/2016)... , Dec. 7, 2016 Boehringer ... trial in patients with unresectable malignant pleural mesothelioma ... (PFS). The data, presented at the 17 th ... Vienna , showed nintedanib plus ... placebo plus pemetrexed/cisplatin, with a significantly improved PFS ...
(Date:12/7/2016)... , Dec. 7, 2016  Organovo Holdings, Inc. ... biology company focused on delivering scientific and medical ... that Chairman and Chief Executive Officer Keith ... on Wednesday, December 14, 2016 at 1:00 p.m. ... are not yet familiar with the Company, an ...
Breaking Medicine Technology: